Abstract:Accumulating evidence suggests that autophagy dysfunction plays a critical role in myocardial ischemia/reperfusion (I/R) injury. However, the underling mechanism of malfunctional autophagy in the cardiomyocytes subjected to I/R has not been well defined. As a result, there is no effective therapeutic option by targeting autophagy to prevent myocardial I/R injury. Here, we used both an in vitro and an in vivo I/R model to monitor autophagic flux in the cardiomyocytes, by exposing neonatal rat ventricular myocytes to hypoxia/reoxygenation and by subjecting mice to I/R, respectively. We observed that the autophagic flux in the cardiomyocytes subjected to I/R was blocked in both in vitro and in vivo models. Down-regulating a lysosomal cationic channel, TRPML1, markedly restored the blocked myocardial autophagic flux induced by I/R, demonstrating that TRPML1 directly contributes to the blocked autophagic flux in the cardiomyocytes subjected to I/R. Mechanistically, TRPML1 is activated secondary to ROS elevation following ischemia/reperfusion, which in turn induces the release of lysosomal zinc into the cytosol and ultimately blocks the autophagic flux in cardiomyocytes, presumably by disrupting the fusion between autophagosomes and lysosomes. As a result, the inhibited myocardial autophagic flux induced by TRPML1 disrupted mitochondria turnover and resulted in mass accumulation of damaged mitochondria and further ROS release, which directly led to cardiomyocyte death. More importantly, pharmacological and genetic inhibition of TRPML1 channels greatly reduced infarct size and rescued heart function in mice subjected to I/R in vivo by restoring impaired myocardial autophagy. In summary, our study demonstrates that secondary to ROS elevation, activation of TRPML1 results in autophagy inhibition in the cardiomyocytes subjected to I/R, which directly leads to cardiomyocyte death by disrupting mitochondria turnover. Therefore, targeting TRPML1 represents a novel therapeutic strategy to protect against myocardial I/R injury.

Transient receptor potential mucolipin 1 circumvents oxidative stress in primary human melanocytes

TRPM2 mediates mitochondria-dependent apoptosis of melanocytes under oxidative stress.

The Protective Effect of EGF-activated ROS in Human Corneal Epithelial Cells by Inducing Mitochondrial Autophagy Via Activation TRPM2.

1190 Demethylation of TRPM2 Induced by Oxidative Stress Triggers Mitochondria-Dependent Apoptosis of Melanocytes

Alpha-melanocyte-stimulating hormone suppresses oxidative stress through a p53-mediated signaling pathway in human melanocytes

Protective Effect of Mitochondria-Targeted Peptide MTP-131 Against Oxidative Stress-Induced Apoptosis in RGC-5 Cells

Role of the Aryl Hydrocarbon Receptor Signaling Pathway in Promoting Mitochondrial Biogenesis Against Oxidative Damage in Human Melanocytes.

044 Oxidative Stress Inducing TRPM2 Activate the NLRP3 Inflammasome in Keratinocytes Resulting in Melanocyte Destruction in Vitiligo

Disruption of Transient Receptor Potential Melastatin 2 Attenuate Lipopolysaccharide-Induced Heme Oxygenase-1 Expression in Mouse Macrophages Through P38 Mitogen-Activated Protein Kinase (P5202)

The mitochondria‒paraspeckle axis regulates the survival of transplanted stem cells under oxidative stress conditions

MITF Acts As an Anti-Oxidant Transcription Factor to Regulate Mitochondrial Biogenesis and Redox Signaling in Retinal Pigment Epithelial Cells.

<scp>HMGB</scp>1 deficiency reduces H<sub>2</sub>O<sub>2</sub>‐induced oxidative damage in human melanocytes via the Nrf2 pathway

TRPM2‐dependent autophagy inhibition exacerbates oxidative stress‐induced CXCL16 secretion by keratinocytes in vitiligo

Blunting TRPML1 channels protects myocardial ischemia/reperfusion injury by restoring impaired cardiomyocyte autophagy

Oxidative Stress-Induced Calreticulin Expression And Translocation: New Insights Into The Destruction Of Melanocytes

Decreased Methionine Sulphoxide Reductase A Expression Renders Melanocytes More Sensitive to Oxidative Stress: A Possible Cause for Melanocyte Loss in Vitiligo

HMGB1 deficiency reduces H 2 O 2 -induced oxidative damage in human melanocytes via the Nrf2 pathway.

Tranilast Directly Targets NLRP3 to Protect Melanocytes from Keratinocyte-Derived IL-1β under Oxidative Stress

Melatonin antagonizes oxidative stress-induced apoptosis in retinal ganglion cells through activating the thioredoxin-1 pathway

Activation of lysosomal Ca2+ channels mitigates mitochondrial damage and oxidative stress

Identification of the Competing Endogenous RNA Networks in Oxidative Stress Injury of Melanocytes.